Hanmi Financial Launches Countmate to Innovate North American Pharmacy Operations

Hanmi Pharmaceutical Expands Its Footprint in North America with Innovative Dispensing Technology

Hanmi Pharmaceutical, headquartered in Seoul, South Korea, is making significant strides in the North American pharmaceutical landscape through its recent partnership with McKesson. On February 14, 2025, the company unveils Countmate, a cutting-edge automated vial dispensing machine tailored for North American pharmacists. This device is designed to address the prevalent use of vials over pouches in medication dispensing, streamlining various processes such as drug counting, labeling, image verification, and final discharge. The introduction of Countmate marks a strategic pivot for Hanmi, as it enhances its product offerings and targets a growing market sector in Canada and the U.S.

CEO Jae-Hyun Park underscores the importance of this launch, describing it as a critical step in expanding JVM Co., Ltd.'s previously pouch-focused product lineup. The transition to vial dispensing technology aligns with Hanmi's broader strategy to cater to the unique operational needs of North American pharmacies, where efficiency and precision in medication dispensing are paramount. By leveraging the capabilities of Countmate, Hanmi aims to not only boost its global sales but also provide a solution that meets the increasing demand for advanced dispensing technologies across the region.

The collaboration with McKesson Automation is pivotal for Hanmi's market entry strategy, reinforcing its commitment to delivering innovative solutions that resonate with North American pharmacists. This partnership was spotlighted at the ASHP 2024 exhibition in New Orleans, where executives from both companies celebrated their collaboration. With the rising demand for automated pharmacy solutions, Hanmi is poised for substantial growth in the North American market, solidifying its competitive edge and enhancing its presence in a landscape that increasingly prioritizes technological advancements in pharmaceutical operations.

In addition to its product innovation, Hanmi Pharmaceutical's strategic alliance with McKesson positions the company favorably amidst a growing trend in the industry. As pharmacies seek to optimize their operations, the demand for automated solutions like Countmate is expected to surge, providing Hanmi with a unique opportunity to establish itself as a leader in this segment. The company's focus on efficiency and reliability in medication dispensing aligns with broader industry shifts, further enhancing its prospects in North America.

As Hanmi Pharmaceutical continues to expand its reach, the introduction of Countmate represents not just a product launch but a significant advancement in the pharmacy sector, highlighting the company’s commitment to innovation and operational excellence in a competitive market.